Brain HIV burden and length of survival after AIDS diagnosis

Clinical Neuropathology

Volumn 17, Issue 2, 1998, Pages 95-99

  Soontornniyomklj, V ^a,c   Nieto Rodriguez J A ^a   Martinez A J ^a   Kingsley, L A ^b   Achim, C L ^a   Wiley, C A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

AIDS; AIDS dementia complex; Encephalitis; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEMENTIA; GIANT CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL TIME; VIRUS DETECTION; VIRUS ENCEPHALITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS DEMENTIA COMPLEX; BRAIN; GIANT CELLS; HIV; HIV ENVELOPE PROTEIN GP41; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; VIRAL LOAD;

EID: 0031916956     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Achim CL, Wang R, Miners DK, Wiley CA 1994 Brain viral burden in HIV infection. J Neuropathol Exp Neurol 53: 284-294
2. Bacellar H, Mun̄oz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthurJC 1994 Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study 1985-1992. Neurology 44: 1892-1900
3. Bell JE, Donaldson YK, Lowrie S, McKenzie CA, Elton RA, Chiswick A, Brertle RP, Ironside JW, Simmonds P 1996 Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 10: 493-499
4. Brew BJ, Rosenblum M, Cronin K, Price RW 1995 AIDS dementia complex and HTV-1 brain infection: Clinical-virological correlations. Ann Neurol 38: 563-570
5. Budka H 1990 Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immunodeficiency syndrome (AIDS). Acta Neuropathol 79: 611-619
6. Budka H 1991 Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163-175
7. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho E-S, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D, Epstein LG, Esiri MM, Giangaspero F, Gosztonyi G, Gray F, Griffin JW, Hénin D, Iwasaki Y, Janssen RS, Johnson RT, Lantos PL, Lyman WD, McArthur JC, Nagashima K, Peress N, Petito CK, Price RW, Rhodes RH, Rosenblum M, Said G, Scaravilli F, Sharer LR, Vinters HV 1991 HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1: 143-152
8. Centers for Disease Control 1987 Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (Suppl): 1S-15S
9. Glass JD, Fedor H, Wesselingh SL, McArthur JC 1995 Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762
10. Glass JD, Wesselingh SL, Selnes OA, McArthur JC 1993 Clinicalneuropathologic correlation in HIV-associated dementia. Neurology 43: 2230-2237
11. Grant I, Heaton RK, Atkinson JH 1995 Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr Top Microbiol Immunol 202: 11-32
12. Gray F, Bélec L, Keohane C, De Truchis P, Clair B, Durigon M, Sobel A, Gherardi R 1994 Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS 8: 489-493
13. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalz C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA 1997 Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med337: 734-739
14. Kibayashi K, Mastri AR, Hirsch CS 1996 Neuropathology of human immunodeficiency virus infection at different disease stages. Hum Pathol 27: 637-642
15. Kure K, Weidenheim KM, Lyman WD, Dickson DW 1990 Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 80: 393-400
16. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA, Jacobson LP, Visscher BR, Concha M, Saah A 1993 Dementia in AIDS patients: Incidence and risk factors. Neurology 43: 2245-2252
17. McArthur JC, Selnes OA, Glass JD, Hoover DR, Bacellar H 1994 HIV dementia: Incidence and risk factors. In: Price RW, Perry SW (eds) HIV, AIDS, and the Brain. Raven Press, New York, pp 251-272
18. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA 1996 Prognosis in HTV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170
19. Mocroft A, Johnson MA, Phillips AN 1996 Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS 10: 1057-1065
20. Navia BA, Cho E-S, Petito CK, Price RW 1986 The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525-535
21. Price RW 1994 Understanding the AIDS dementia complex: The challenge of HIV and its effects on the central nervous system. In: Price RW, Perry SW (eds) HIV, AIDS, and the Brain. Raven Press, New York, pp 1-45
22. Wiley CA, Achim C 1994 Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome (published erratum appears in Ann Neurol 1995 37: 140). Ann Neurol 36: 673-676